Rethinking the Science of COPD
We are working to transform the way COPD is understood and treated.
Our Latest Stories
Our Science
November 13, 2024
How Immunoscience is Transforming Treatment for Type 1 Diabetes
Third quarter 2024 results
Third quarter 2024 results were reviewed by management during a conference call with the financial community on Friday October 25, 2024. The presentation was followed by a Q&A session.
United by Purpose
Each of us plays a unique role in bringing our purpose to life.
Igniting the Potential in Everyone
We’re proud to be premium partner of Paris 2024.
Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends.
About Us
Who We Are
We are an innovative global healthcare company.
Our Pipeline
5
Therapeutic areas
78
Compounds in clinical development
27
Clinical trials in phase 3
Pursue Progress. Discover Extraordinary.
Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.